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All transhydrogenases appear to have three components: dI, which binds NAD(H), and dIII, which binds NADP(H), protrude from the
membrane, and dII spans the membrane. However, the polypeptide composition of the enzymes varies amongst species. The transhydrogenases of
Mycobacterium tuberculosis and of Rhodospirillum rubrum have three polypeptides. Sequence analysis indicates that an ancestral three-
polypeptide enzyme evolved into transhydrogenases with either two polypeptides (such as the Escherichia coli enzyme) or one polypeptide (such
as the mitochondrial enzyme). The fusion steps in each case probably led to the development of an additional transmembrane helix. A hybrid
transhydrogenase was constructed from the dI component of the M. tuberculosis enzyme and the dII and dIII components of the R. rubrum
enzyme. The hybrid catalyses cyclic transhydrogenation but not the proton-translocating, reverse reaction. This shows that nucleotide-binding/
release at the NAD(H) site, and hydride transfer, are fully functional but that events associated with NADP(H) binding/release are compromised. It
is concluded that sequence mismatch in the hybrid prevents a conformational change between dI and dIII which is essential for the step
accompanying proton translocation.
© 2006 Elsevier B.V. All rights reserved.Keywords: Transhydrogenase; Rhodospirillum rubrum; Mycobacterium tuberculosis; Proton translocation; Nicotinamide nucleotides; Phylogenetic tree1. Introduction
Transhydrogenases are found in the inner mitochondrial
membrane of mammalian cells and in the cytoplasmic
membrane of bacteria. The enzymes couple the transfer of
hydride-ion equivalents between NAD(H) and NADP(H) to the
translocation of protons across the membrane:
NADHþ NADPþ þ Hþp X NADþ þ NADPHþ Hþn ð1Þ
where H+p signifies H
+ on the cytoplasmic side of the
membrane in mitochondria and the extra-cellular side in
bacteria. The reaction is normally driven from left to right byAbbreviations: AcPdAD+, acetylpyridine adenine dinucleotide (oxidised
form); Nic+, nicotinamide; NicH, dihydronicotinamide; NAD(H), both NAD+
and NADH
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doi:10.1016/j.bbabio.2006.03.004the inward translocation of H+ down the proton electrochemical
gradient (Δp) generated by the respiratory (or sometimes
photosynthetic) electron transport chains. NADPH produced by
transhydrogenases is used in biosynthesis reactions [1] and for
the reduction of glutathione, needed to limit damage caused by
oxidative stress [2,3]. Knock-down of transhydrogenase in
MIN6 mouse cells led to a reduction of insulin secretion [4]. In
some animal cells, transhydrogenase together with the iso-
citrate dehydrogenases, might also participate in the regulation
of flux through the tricarboxylic acid cycle [5,6].
The enzyme has three components, dI, dII and dIII (see
reviews [7–11]). The dI component, which binds NAD(H), and
the dIII component, which binds NADP(H), protrude from the
membrane (on the matrix side in mitochondria and on the
cytoplasmic side in bacteria). The dII component, which houses
the proton-translocation pathway, spans the membrane. Al-
though the global architecture of transhydrogenases appears to
be similar, the polypeptide composition varies amongst species
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single polypeptide, active as a dimer. Transhydrogenases of this
type are placed in the 1Pa group. There is also a single
polypeptide in transhydrogenases from Protoctistal organisms
such as Entamoeba histolytica (the 1Pb group) but here the dI–
dII–dIII connectivity differs from that in the mitochondrial
enzymes. In the eubacteria, there are two different subunit
arrangements. In some species (Escherichia coli is an example),
transhydrogenase has two polypeptides (they are active as an
α2β2 dimer)—this is the 2P group. In other species, such as
Rhodospirillum rubrum, the enzyme has three polypeptides
(again probably active in a dimeric form)—the 3P group. To
date, sequences for proton-translocating transhydrogenases
have not been found in either the archaea or higher plants.
Fig. 1a shows how the dI, dII and dIII components are arranged
along the polypeptide chains. Note that, in the 3P transhy-
drogenases, the dI component is located on its own polypeptide
(PntAA) whereas, in the 2P group and both the 1P groups, dI is
covalently linked through the polypeptide chain to the N-
terminal region of dII. There are currently (from September
2005) 14 complete sequences in the database having the 1Pa
organisation, 5 having 1Pb, 38 having 2P, and 50 sequences
having the 3P organisation.
Recombinant forms of dI and dIII have been prepared from
several species, where necessary introducing stop and start
codons into the DNA sequences [12–18]. The dI and dIII
proteins of R. rubrum transhydrogenase are amenable to high-
resolution structure determinations by X-ray crystallography
and NMR [19–21]. Of particular interest is a complex formed
between these two components. The “dI2dIII1 complex”Fig. 1. The structure of transhydrogenase. (A) Variation in polypeptide
composition (horizontal bars). Vertical lines delineate the dI, dII and dIII
components (see text); vertical gaps delineate the polypeptides. The vertical
alignment represents sequence similarity. The dashed line on the Ent. histolytica
enzyme illustrates that the C-terminus of dIII and the N-terminus of dI are fused.
PntAA, PntAB and PntB are the designated names of the three polypeptides of
R. rubrum transhydrogenase [51] and other enzymes in the 3P group. The group
notation, at the right, is defined in the text. (B) The probable component
organisation of intact transhydrogenase [24]. The dotted line illustrates the dI–
dIII “linker polypeptide”, which is present in 1P and 2P transhydrogenases but
absent in the 3P group (see text). The grey shade in panels A and B shows the
regions comprising trans-membrane helices. For simplicity, the polypeptide
separation in the dII component of the 2P and 3P transhydrogenases (see panel
A) is not depicted in panel B.catalyses rapid, direct hydride transfer between bound NAD
(H) and bound NADP(H) [22,23]. X-ray structures of the
complex show how apposition of the dihydronicotinamide ring
of NADH and the nicotinamide ring of NADP+ facilitates
hydride transfer with a stereochemistry matching that deter-
mined experimentally [24–26]. In the intact enzyme, the
hydride-transfer site at the interface between dI and dIII, is
probably some >30 Å from the proton translocation pathway
through dII. The two processes are thought to be coupled by
conformational changes across dIII.
Although their amino acid sequences are only distantly
related, the transhydrogenase of Mycobacterium tuberculosis
like that of R. rubrum is in the 3P group (Fig. 1A). As part of a
study to investigate the properties of the M. tuberculosis
transhydrogenase, we have prepared a hybrid of the two
enzymes. The hybrid, comprising M. tuberculosis dI and R.
rubrum dII/dIII, catalyses rapid hydride transfer between bound
nucleotides but is unable to carry out the complete, proton-
translocating transhydrogenase reaction. This finding has
implications for the mechanism of energy coupling during
transhydrogenation. Previous attempts to construct a hybrid
transhydrogenase using R. rubrum dII/dIII and the dI from
either E. coli or Entamoeba histolytica were unsuccessful
[18,27]. The activity of the R. rubrum–M. tuberculosis hybrid,
therefore, provides new information about subunit interactions
in transhydrogenase.
2. Materials and methods
Cultures of R. rubrum strain S1 were grown photo-heterotrophically and
chromatophores (inverted cytoplasmic-membrane vesicles) were prepared, as
described [28]. The chromatophores were depleted of their transhydrogenase dI
by washing repeatedly by centrifugation in 100 mM Tris–HCl, pH 8.0, 10%
sucrose. The bacteriochlorophyll content of the membranes was measured using
the in vivo extinction coefficient given [29].
The gene encoding the transhydrogenase dI component was isolated by
PCR using DNA extracted from M. tuberculosis strain H37Rv and the
primers, 5′-GGA TCC AAT GAC AGA TCC GCA GAC GCA GAG C-3′
(BamHI site underlined) and 5′-AAG CTT GGA GTC CCT CCC GCG GGT
GAC-3′ (HindIII site underlined). The resulting 1098 base-pair fragment was
ligated into the SmaI site of pUC18 and the construct was transformed into E.
coli Top 10 cells (Invitrogen). Subsequently prepared plasmid DNA from
these cells was digested with BamHI and HindIII, and the dI-encoding DNA
was isolated and ligated into pET23b to generate pRW1. The fidelity of the
PCR was confirmed by DNA sequence analysis. The construct was
transformed into E. coli C41(DE3) [30]. Overnight pre-cultures were used
to inoculate Terrific Broth and the cells were grown at 37 °C to an optical
density of 1.2 and then induced with 1 mM isopropyl thiogalactoside. After
further incubation for 12–16 h at 16 °C, the cells were harvested by
centrifugation. The cell pellet was re-suspended in 0.5 M NaCl, 100 mM
imidazole, 20 mM sodium phosphate, pH 7.4 containing DNAse, RNAse,
complete protease inhibitor (Roche) and 0.1 mg ml−1 lysozyme. The bacteria
were disrupted with a Soniprep 150. The extract was centrifuged at 27,000×g
for 60 min at 4 °C and the supernatant applied to a 1 ml Ni2+-charged His-
Trap column (Pharmacia). The column was washed extensively with
0.5 M NaCl, 100 mM imidazole, 20 mM sodium phosphate, pH 7.4, and
protein was then eluted by a stepwise increase in imidazole concentration
(150, 200, 300 and 500 mM). The dI protein was eluted typically at around
200 mM and was pooled, dialysed against 50 mM Tris–HCl, pH 7.5,
containing 10% glycerol and stored at −20 °C. It was approximately 95%
pure by analysis on SDS-PAGE. The recombinant dI and dIII components of
R. rubrum transhydrogenase were expressed from pCD1 and pNIC2 in E. coli
strains C600 and BL21 (DE3), respectively, and purified by column
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determined using the micro-tannin assay [32].
Isothermal-scanning calorimetry was performed on the MicroCal MCS
system. The thawed dI was prepared for experiments by concentrating in a
10 kDa Vivaspin filter and then dialysed against 10 mM (NH4)2SO4, 20 mM
HEPES, pH 8.0. Binding constants were determined using the ORIGIN program
as supplied by the instrument manufacturer.
Transhydrogenation rates were measured by following the reduction of
acetylpyridine adenine dinucleotide (AcPdAD+) at 375 nm (extinction
coefficient, 6.2 mM−1 cm−1) in a Shimadzu UV2401 spectrophotometer.
Amino acid sequence analysis was performed using ClustalW [33] within
the program, BIOEDIT, and phylogenetic analysis [34,35] was carried out using
the program, PAUP (see legend to Fig. 7). Hydropathy profiles with a scan
window of 13 [36] were constructed within BIOEDIT. Root mean square
deviations between 3D structures of transhydrogenase were calculated using the
program SwissPDBViewer.Fig. 3. Rates of transhydrogenation in dI-depleted chromatophore membranes
with added rrdI and added mtdI. (A) R. rubrum chromatophores were washed to
remove dI as described in Materials and methods. The dI-depleted membranes
were suspended (to give a bacteriochlorophyll concentration of 10 μM) in
20 mM Tris–HCl, pH 7.2, 50 mM KCl, 2 mM MgCl2, 10 mM (NH4)2SO4,
125 mM sucrose, 200 μMNADPH and the dI concentration shown in the figure.
The reaction was initiated by addition of AcPdAD+ (final concentration
200 μM). Closed symbols, rrdI, open symbols, mtdI. Note that the residual
transhydrogenation rate observed in the absence of any added dI may be
attributable partly to dI that has not been removed in the washing step, and partly
+3. Results
3.1. Interactions between dI of M. tuberculosis and dII/dIII of
R. rubrum transhydrogenase
A His-tagged version of the dI component ofM. tuberculosis
transhydrogenase (hereafter called mtdI) was expressed at high
levels from a pET-based vector in cells of E. coli C41 (DE3).
After cell breakage, the protein was located in the soluble
fraction and was purified by Ni2+ chromatography. The yield of
the final product (>95% pure from the staining intensity on
SDS-PAGE) was approximately 100 mg l−1 of bacterial culture.
A protein probably equivalent to mtdI was previously isolated
from a homogenate ofM. tuberculosis H37Rv and characterised
by SDS-PAGE [37].
The binding of NADH to mtdI was demonstrated in
calorimetry experiments (Fig. 2). The Kd (35 μM) was in the
same order as that for R. rubrum dI (rrdI—20 μM [38]) and E.
coli dI (ecdI—45 μM [39]). However, under similar experi-Fig. 2. Heat changes accompanying the binding of NADH to mtdI. The
calorimeter cell contained 1.8 ml of mtdI (350 μM) in 10 mM (NH4)2SO4,
20 mM HEPES, pH 8.0. The injection syringe contained 5.2 mM NADH in the
same buffer. Each data point corresponds to a single 1.0 μl injection; the
injections were 210 s apart. The temperature was 20 °C. The curve shows the
binding isotherm calculated by ORIGIN. Kd=35 μM, ΔH=−1.8 kCal mol−1.
to low rates of AcPdAD reduction by NADPH catalysed by other enzymes in
the chromatophore membranes. (B) As in panel A, but with 10 nM rrdI present
throughout. The final concentration of mtdI was varied as shown.
BChl=bacteriochlorophyll.mental conditions, the heat change was smaller for mtdI (ΔH ≈
−1.8 Kcal mol−1) than for rrdI.
Chromatophore membranes from R. rubrum have an active
transhydrogenase. When the membranes are washed by
centrifugation in the absence of NADP+ and Mg2+, the
transhydrogenase activity is lost [28,40] due to dissociation
and removal of the rrdI polypeptide. The activity can be fully
restored to the depleted membranes by addition of recombinant
rrdI [13]. In the experiment of Fig. 3A, the transhydrogenation
reaction was measured as the reduction of AcPdAD+ by
NADPH- essentially the reverse of Eq. (1) but with the analogue
substituting for NAD+. The reaction drives inward proton
translocation [41]. In contrast to the experiments with rrdI, the
addition of mtdI to dI-depleted R. rubrum membranes had no
restorative effect on reverse transhydrogenation. Fig. 3B shows,
however, that mtdI does bind under these conditions. Enough
rrdI was added to dI-depleted membranes to give partial
restoration of the reverse transhydrogenase activity. Subsequent
Fig. 5. The mtdI–rrdII–rrdIII hybrid transhydrogenase catalyses rapid cyclic
transhydrogenation. Experiments were performed as in Fig. 3A except that
200 μM NADH was additionally present in the assay medium. Closed symbols,
rrdI, open symbols, mtdI.
218 R. Wilson et al. / Biochimica et Biophysica Acta 1757 (2006) 215–223addition of mtdI then led to inhibition, presumably by
competing with rrdI for dII/dIII sites in the membrane.
In the presence of low concentrations of either NADP+ or
NADPH, transhydrogenase can catalyse the reduction of
AcPdAD+ by NADH—the so-called cyclic reaction. This can
simply be the sum of reverse transhydrogenation (with
AcPdAD+ replacing NAD+, Eq. (2) and forward transhydro-
genation (Eq. (1)):
AcPdAD þ þ NADPHþ Hþn $ AcPdADHþ NADPþ þ Hþp
ð2Þ
AcPdADþ þ NADH X AcPdADHþ NADþ
sum of Eqs: ð1Þ and ð2Þ:
Here, reverse and forward transhydrogenation drive proton
translocation in opposite directions across the membrane and
there is no net generation of Δp. However, as shown in the
scheme in Fig. 4, the cyclic reaction can take place without
either NADP+ or NADPH leaving the enzyme. Thus, steps 1
and 2 in Fig. 4 are entirely sufficient to complete the process.
Under these conditions, proton translocation does not occur
across the membrane in either direction [42]. This is an
important indication that the proton translocation reactions of
transhydrogenase are not associated with the redox reaction but
are linked specifically to the steps involved in NADP+/NADPH
binding and release (the dashed lines in Fig. 4)—and see [43].
The data in Fig. 5 show that, in contrast to the results on reverse
transhydrogenation, mtdI can restore cyclic transhydrogenation
to dI-depleted chromatophores almost as well as rrdI. The
dependences on dI concentration are similar for the two
proteins, indicating a similar affinity for the membrane-located
dII/dIII binding sites.Fig. 4. Scheme for the mechanism of cyclic transhydrogenation. E=transhy-
drogenase. The solid arrows show the cyclic reaction taking place on the
enzyme. The dashed lines show possible association and dissociation of NADP
(H) from the enzyme. The latter steps are compulsorily involved in forward and
reverse transhydrogenation.Mixtures of recombinant rrdI and rrdIII readily form a
dI2dIII1 complex. NAD(H) and AcPdAD(H) can bind to, and
dissociate from, the dI component of the complex very rapidly,
and the bound nucleotides can then undergo fast hydride
transfer with NADP(H) bound to the dIII component [23].
However, bound NADP(H) can exchange only very slowly with
NADP(H) in the solvent [12]. Thus, in the absence of the
membrane-spanning dII, the complex catalyses forward and
reverse transhydrogenation only at extremely low rates (limited
by the slow release of product NADPH and NADP+,
respectively) but it can carry out a rapid cyclic reaction with
NADP+ and NADPH remaining tightly bound (Fig. 6).
Admixture of mtdI and rrdIII also led to the formation of a
complex capable of catalysing rapid rates of cyclic transhy-
drogenation. The similar concentration dependences indicate
that rrdI and mtdI bind to rrdIII with similar affinities.
3.2. Phylogenetics of transhydrogenase
Fig. 7 shows a phylogenetic tree derived from representative
transhydrogenase sequences. As with other proteins [44,45], the
tree differs greatly from that determined using sequences of 16s
RNA [46] indicating the importance of horizontal gene transferFig. 6. Rapid cyclic transhydrogenation in complexes of rrdIII and either rrdI or
mtdI. Reactions were performed in 50 mM Mops, pH 7.2, 50 mM KCl, 2 mM
MgSO4, 200 μM AcPdAD
+, 200 μM NADH, and either 50 nM rrdI (closed
symbols) or 50 nM mtdI (open symbols); rrdIII was added to give the
concentration shown.
Fig. 7. Phylogenetic tree of transhydrogenase amino acid sequences. Amino acid sequences were aligned using ClustalW [33] and manually adjusted in BIOEDIT.
Only representative species from representative genera are shown. The assignment of each transhydrogenase to the 1Pa, 1Pb, 2P and 3P groups is based on predictions
of polypeptide composition from the gene sequences, as defined in Fig. 1A. Up to September 2005, no transhydrogenase sequence was found that violates the
illustrated relationship between the clade organisation and the polypeptide composition. The tree was constructed using a maximum parsimony method [34]. Statistical
analysis gave good bootstrap values (>80%). A tree constructed using a neighbour-joining method [35] was almost identical, though it placed the transhydrogenase
from Entamoeba histolytica on a different branch from those of Eimeria and Plasmodium species. Regions F1, F2 and F3 are defined in the text.
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defined by the transhydrogenase tree precisely match the
groupings defined by polypeptide organisation (Fig. 1)—the
1Pa, 1Pb, 2P and 3P groups align with related clades.
Horizontal transfer of DNA within the transhydrogenase
genes has not significantly disturbed the relationship. We can,
therefore, determine where fusions probably led to the
emergence of the different groups of transhydrogenases
described in Fig. 1A. Thus, a mutation leading to fusion of
the C-terminus of PntAA and the N-terminus of PntAB in an
ancestral 3P transhydrogenase at a point near F1 in Fig. 7 led to
the development of all members of the 2P group. Subsequentlyto this, two different fusions led to the 1Pa and the 1Pb groups
from ancestral 2P transhydrogenases. Near F2, a fusion of the
C-terminus of (what had been) PntAB and the N-terminus of
PntB led to all members of 1Pa. Similarly near F3, a fusion of
the C-terminus of PntB with the N-terminus of (what had been)
PntAA led to all members of 1Pb. Other evolutionary pathways
are unlikely because they would have involved either multiple
fusion events at a similar position or mutations leading to
polypeptide cleavage, which have more demanding require-
ments to ensure survival of the protein [47]. The proposed
pathway places the root of the transhydrogenase tree within the
3P clades of Fig. 7.
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polypeptide fusion leading to emergence of the 2P group from
the 3P group was coupled to the formation of an additional
transmembrane helix (TMH). Thus, TMH1, which was
predicted from the amino acid sequence of bovine transhy-
drogenase [48], and whose presence was confirmed experi-
mentally in the E. coli enzyme [49], is evident in hydropathy
profiles of all 2P, 1Pa and 1Pb species (Fig. 8). However, TMH1
is missing from all enzymes in the 3P group. It was noted [50]
that the N-terminal amino acid sequence of PntAB of the M.
tuberculosis enzyme is short and is unlikely to comprise a
segment homologous with TMH1. Furthermore, though the
equivalent sequence in R. rubrum is long enough, it is probably
too hydrophilic to form a TMH [9,51]. As more sequences have
been deposited in the database, these patterns are repeated
across the 3P group—the N-terminal sequence of the PntAB
polypeptide is either too short or too hydrophilic to form TMH1
(Fig. 8). Since dI is in the bacterial cytoplasm [28] and the N-
terminus of TMH2 is in the periplasm [49], polypeptide fusion
during evolution of the 2P group from the 3P group (at F1 in
Fig. 7) required passage of the chain across the membrane
(eventually) to generate TM1.
Equivalently, it is likely that TMH5 was later formed (at F2
in Fig. 7) during the emergence of the 1Pa transhydrogenases
from their common ancestor in the 2P group by fusion of the C-
terminus of (what had been) PntAB and the N-terminus of PntB.
These termini are located in the cytoplasm and periplasm,Fig. 8. Hydropathy profiles of amino acid sequences for putative transmembrane
helices 1–6 of transhydrogenases. Segments of hydropathy profiles [36] for
sequences of all the species in Fig. 7, aligned as described in Materials and
methods, are illustrated. The panels show profiles for the 3P, 2P, 1Pa and 1Pb
groups, as indicated in the right-hand column. The numbers across the top of
each panel indicate predicted TMH using the bovine numbering system [48].
“Missing” helices (see text) are marked by a x. The horizontal flat lines arise
from gaps introduced during sequence alignment—note that the hydropathy
profiles tend to merge at the gaps. The arrows show sequence numbers for the
bovine enzyme. Hydrophilic inserts into the amino acid sequences of
Plasmodium falciparum and P. berghei (both from the 1Pb group) result in
distortion of the hydropathy profiles of putative TMH 3 and 4, respectively; the
transhydrogenases from these species have not been isolated to verify the
properties of the proteins.respectively [49], and this event too would have required
passage of a segment of the polypeptide chain across the
membrane. Consistent with this version of events, TMH5 is not
predicted by hydropathy profiles in any of the 2P or 3P groups
but is strongly predicted in all the 1Pa group (Fig. 8).
Interestingly, the insertion of a short polypeptide corresponding
to TMH5 of the bovine transhydrogenase between the two
polypeptides of the E. coli enzyme led to an active protein [52].
In contrast, during the emergence of the 1Pb group, the
mutational event at F3 (Fig. 7) led to fusion of the membrane-
peripheral, dI and dIII components of transhydrogenase (for
example, see [18]). It did not involve the transmembrane region
and, therefore, is predicted not to have resulted in the creation of
TMH5. Consistent with this, hydropathy profiles suggest the
absence of this helix in the 1Pb group (Fig. 8).
4. Discussion
Isolated rrdI forms a high-affinity, redox-active complex
with isolated rrdIII [12,15], and also somewhat weaker
complexes with isolated bovine dIII [14], human dIII [17], E.
coli dIII [53] and En. histolytica dIII [18]. In the intact R.
rubrum transhydrogenase, dI exists as a separate polypeptide
(PntAA in Fig. 1) but the dI components of transhydrogenases
from (amongst others) E. coli [54] and En. histolytica [55] are
linked through their respective polypeptide chains to the N-
termini of their dII components. The isolated forms of these two
latter dI proteins (obtained after appropriately engineering the
gene sequences) make only very low-affinity complexes with
rrdIII and even with their own dIII [16,18]. In the present work,
we have expressed and purified dI from M. tuberculosis
transhydrogenase. We find that, like rrdI, mtdI readily forms a
tight, redox-active complex with rrdIII. This is despite the fact
that the R. rubrum andM. tuberculosis transhydrogenases are in
widely separated clades of the phylogenetic tree (Fig. 7) and
have less sequence identity with one another (41%) than, for
example, the R. rubrum enzyme has with the E. coli enzyme
(48%). The results support the suggestion of the Rydstrom
group [56,57] that the nature of the interaction between dI and
dIII depends on whether or not dI and dII are covalently linked
through the polypeptide chain in the intact enzyme. It was
envisaged that, because of the structural organisation of the
intact enzyme (Fig. 1B), the presence of a dI–dII linker (i.e., in
the 1P and 2P transhydrogenases) stabilises the dI–dIII
interaction, and that absence of the linker (i.e., in the 3P
transhydrogenases) is compensated by tighter binding at the dI/
dIII contact surfaces. Thus, in the latter case, isolated dI–dIII
complexes are intrinsically more stable. Two conserved basic
residues in dI at its interface with dIII in most of the 3P group
(Lys192 and Arg193 in R rubrum transhydrogenase) but not the
2P group [57] might be partly responsible for the suggested
stabilisation.
Evolution of the dI–dII linker probably involved the
generation of an extra transmembrane helix (TMH1) during
the emergence of the 2P from the 3P group (see above and Fig.
8) as well as a polypeptide segment stretching across the surface
of dIII (Fig. 1). These features probably affect the balance of
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above, but we think it is unlikely that they have great
mechanistic significance. The view that, in E. coli, the dI–dII
linker region itself contributes to the coupling mechanism, and
that it participates in the transfer of information on nucleotide
binding to the membrane-spanning dII [57], seems highly
unlikely to us in view of the very similar catalytic properties of
the R. rubrum and E. coli enzymes. Furthermore, the degree of
structural similarity between R. rubrum dI (PDB, 1F8G [19])
and E. coli dI (PDB, 1X13 [57]) is in the range expected for
proteins in the same family given their approximately 44%
sequence identity: the root mean square deviation between the
A-chain of the two proteins is 0.99 Å for 333 pairs of Cα atoms
(excluding the “mobile loop” region [58] and the 8 amino acid
residues at the C-terminus of rrdI)—see [59]. The mechanism
of coupling between hydride transfer and proton translocation
probably developed before evolutionary separation of the 1P, 2P
and 3P groups. We would also anticipate that the development
of TMH5 during the emergence of the 1Pa group and of the
fusion of dIII and dI in the formation of the 1Pb group had little
impact on the mechanism of transhydrogenase. The root mean
square deviation between R. rubrum dIII (PDB, 1HZZ [24] and
human dIII (PDB, 1DJL [60]) is only 0.84 Å on 162 pairs of Cα
atoms. Given their 38% sequence identity, this is again a typical
value for related proteins.
From a mechanistic perspective, the most interesting
observation in the present work is that an intact hybrid enzyme
has been constructed (mtdI–rrdII–rrdIII) which catalyses a
rapid cyclic reaction but not the proton-translocating, reverse
transhydrogenase reaction (Figs. 3 and 5). Cyclic and reverse
transhydrogenation share several steps. These are the binding of
AcPdAD+, hydride transfer from NADPH to AcPdAD+ and the
release of AcPdADH. Because the cyclic reaction is fast in
mtdI–rrdII–rrdIII, all these individual steps must proceed at a
substantial rate in the hybrid enzyme. Reverse transhydrogena-
tion additionally requires an NADPH-binding step and an
NADP+-release step (shown in dashed lines in Fig. 4), which
are not involved in the cyclic reaction: the defect in reverse
transhydrogenation in the hybrid, must result because either one
or both of these is inoperative.
The finding that hydride transfer is rapid in a number of
inter-species hybrid dIdIII complexes, and now in a hybrid
intact enzyme, is remarkable. Stopped-flow experiments
showed that hydride transfer between the bound nucleotides
in dIdIII complexes is direct – there are no protein-associated
redox intermediates [22] – and crystal structures show that
the C4N atoms of the dihydronicotinamide (NicH) and
nicotinamide (Nic+) rings are brought into apposition to
effect the reaction [25]. The C4N-to-C4N distance and the ring
orientation is critical in determining the hydride-transfer rate
and, therefore, the dI component, bearing NAD(H), and the
dIII component, bearing NADP(H), must be precisely aligned
in this reaction step. Indeed, amino acid residues in the
contact sites between the dI(A), dI(B) and dIII polypeptides
of the R. rubrum dI2dIII1 complex are strongly conserved
[24]. The low tolerance towards mutation in the contact
regions must partly reflect the importance of preserving theNicH/Nic+ geometry, and thus the rapid rate of hydride
transfer across the domain interface.
The crystal structure of the dI2dIII1 complex suggests that dI
in the intact enzyme interfaces with dIII but not with dII [24]
(see Fig. 1b). The failure in reverse transhydrogenation in the
mtdI–rrdII–rrdIII hybrid must, therefore, arise from a mis-
match at the mtdI/rrdIII interface. As described above, the
defect is attributable to a blockage in the steps associated with
NADPH binding and/or NADP+ release. Notably, these are the
steps that are thought to be coupled to proton translocation
[42,43]. Now NADP(H) binding is to dIII, and proton
translocation is through dII. Neither of these processes directly
involve dI. Thus, the present results indicate that, in wild-type
enzymes, NADP(H) binding/release and H+ translocation are
also coupled to an event that leads to a conformational change
across the interface between dI and dIII, and that this
conformational change is compromised in the hybrid. The
crucial change in interaction between dI and dIII during coupled
turnover is that required to enable the hydride-transfer gate as
the enzyme moves from an open to an occluded state [7,8]: the
gate involves the movement of the Nic(H) ring of NAD(H) from
a distal position to a proximal position relative to the Nic(H)
ring of NADP(H). The emerging picture is that proton
translocation through the membrane-spanning dII leads to
coupled conformational changes that spread across both of the
peripheral components of the enzyme.
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